New drug tracked in kidney disease study
Disease control
Not yet recruiting
This study follows 50 adults with IgA nephropathy who are taking sparsentan. Researchers will measure changes in albuminuria (protein in urine) to see how well the drug controls the disease. The study is observational, meaning it just watches what happens in real-world use, witho…
Sponsor: Waid City Hospital, Zurich • Aim: Disease control
Last updated May 19, 2026 11:03 UTC